Works matching IS 20959907 AND DT 2025 AND VI 10 AND IP 1

Results: 145
    1
    2
    3
    4
    5

    First-line treatment of anti-EGFR monoclonal antibody cetuximab β plus FOLFIRI versus FOLFIRI alone in Chinese patients with RAS/BRAF wild-type metastatic colorectal cancer: a randomized, phase 3 trial.

    Published in:
    Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02229-4
    By:
    • Shi, Yuankai;
    • Ba, Yi;
    • Wang, Junye;
    • Xiong, Jianping;
    • Gu, Kangsheng;
    • Chen, Yigui;
    • Zheng, Zhendong;
    • Wang, Zishu;
    • Guo, Weijian;
    • Cheng, Ying;
    • Yin, Xianli;
    • Liu, Yunpeng;
    • Bai, Yuxian;
    • Li, Enxiao;
    • Li, Qi;
    • Zhu, Liangjun;
    • Li, Wei;
    • Jiang, Da;
    • He, Jingdong;
    • Chen, Jiansi
    Publication type:
    Article
    6
    7
    8
    9
    10

    Multipronged SMAD pathway targeting by lipophilic poly(β-amino ester) miR-590-3p nanomiRs inhibits mesenchymal glioblastoma growth and prolongs survival.

    Published in:
    Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02223-w
    By:
    • Korleski, Jack;
    • Sall, Sophie;
    • Luly, Kathryn M.;
    • Johnson, Maya K.;
    • Johnson, Amanda L.;
    • Khela, Harmon;
    • Lal, Bachchu;
    • Taylor, TC;
    • Ashby, Jean Micheal;
    • Alonso, Hector;
    • Li, Alice;
    • Zhou, Weiqiang;
    • Smith-Connor, Karen;
    • Hughes, Russell;
    • Tzeng, Stephany Y.;
    • Laterra, John;
    • Green, Jordan J.;
    • Lopez-Bertoni, Hernando
    Publication type:
    Article
    11
    12
    13

    Single-cell transcriptomic analysis reveals gut microbiota-immunotherapy synergy through modulating tumor microenvironment.

    Published in:
    Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02226-7
    By:
    • Cao, Minyuan;
    • Deng, Yun;
    • Hao, Qing;
    • Yan, Huayun;
    • Wang, Quan-Lin;
    • Dong, Chunyan;
    • Wu, Jing;
    • He, Yajiao;
    • Huang, Li-Bin;
    • Xia, Xuyang;
    • Gao, Yongchao;
    • Chen, Hai-Ning;
    • Zhang, Wei-Han;
    • Zhang, Yan-Jing;
    • Zhuo, Xiaozhen;
    • Dai, Lunzhi;
    • Hu, Hongbo;
    • Peng, Yong;
    • Zhang, Feng;
    • Liu, Zhaoqian
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Subnanomolar MAS-related G protein-coupled receptor-X2/B2 antagonists with efficacy in human mast cells and disease models.

    Published in:
    Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02209-8
    By:
    • Al Hamwi, Ghazl;
    • Alnouri, Mohamad Wessam;
    • Verdonck, Sven;
    • Leonczak, Piotr;
    • Chaki, Shaswati;
    • Frischbutter, Stefan;
    • Kolkhir, Pavel;
    • Matthey, Michaela;
    • Kopp, Constantin;
    • Bednarski, Marek;
    • Riedel, Yvonne K.;
    • Marx, Daniel;
    • Clemens, Sophie;
    • Namasivayam, Vigneshwaran;
    • Gattner, Susanne;
    • Thimm, Dominik;
    • Sylvester, Katharina;
    • Wolf, Katharina;
    • Kremer, Andreas E.;
    • De Jonghe, Steven
    Publication type:
    Article
    24
    25
    26
    27
    28

    Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trial.

    Published in:
    Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02208-9
    By:
    • Bian, Huijie;
    • Chen, Liang;
    • Zhang, Zheng;
    • Wen, Ai-Dong;
    • Zheng, Zhao-Hui;
    • Song, Li-Qiang;
    • Yao, Meng-Ying;
    • Liu, Ying-Xia;
    • Zhang, Xi-Jing;
    • Dong, Hong-Lin;
    • Lian, Jian-Qi;
    • Pan, Lei;
    • Liu, Yu;
    • Gu, Xing;
    • Zhao, Hui;
    • Wang, Jing-Wen;
    • Wang, Qing-Yi;
    • Zhang, Kui;
    • Jia, Jun-Feng;
    • Xie, Rong-Hua
    Publication type:
    Article
    29
    30
    31
    32

    Deep insight into cytokine storm: from pathogenesis to treatment.

    Published in:
    Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02178-y
    By:
    • Nie, Jiali;
    • Zhou, Ling;
    • Tian, Weiwei;
    • Liu, Xiansheng;
    • Yang, Liping;
    • Yang, Xingcheng;
    • Zhang, Yicheng;
    • Wei, Shuang;
    • Wang, Dao Wen;
    • Wei, Jia
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Phototherapy in cancer treatment: strategies and challenges.

    Published in:
    Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02140-y
    By:
    • Cai, Yeyu;
    • Chai, Tian;
    • Nguyen, William;
    • Liu, Jiayi;
    • Xiao, Enhua;
    • Ran, Xin;
    • Ran, Yuping;
    • Du, Dan;
    • Chen, Wei;
    • Chen, Xiangyu
    Publication type:
    Article
    45
    46
    47
    48
    49
    50

    Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs.

    Published in:
    Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02180-4
    By:
    • Gremke, Niklas;
    • Besong, Isabelle;
    • Stroh, Alina;
    • von Wichert, Luise;
    • Witt, Marie;
    • Elmshäuser, Sabrina;
    • Wanzel, Michael;
    • Fromm, Martin F.;
    • Taudte, R. Verena;
    • Schmatloch, Sabine;
    • Karn, Thomas;
    • Reinisch, Mattea;
    • Hirmas, Nader;
    • Loibl, Sibylle;
    • Wündisch, Thomas;
    • Litmeyer, Anne-Sophie;
    • Jank, Paul;
    • Denkert, Carsten;
    • Griewing, Sebastian;
    • Wagner, Uwe
    Publication type:
    Article